Suppr超能文献

住院成人中耐碳青霉烯类肺炎克雷伯菌感染的预测因素及感染对死亡率的影响。

Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.

作者信息

Schwaber Mitchell J, Klarfeld-Lidji Shiri, Navon-Venezia Shiri, Schwartz David, Leavitt Azita, Carmeli Yehuda

机构信息

Division of Epidemiology and Preventive Medicine, Tel Aviv Sourasky Medical Center, 6 Weizmann St., Tel Aviv 64239, Israel.

出版信息

Antimicrob Agents Chemother. 2008 Mar;52(3):1028-33. doi: 10.1128/AAC.01020-07. Epub 2007 Dec 17.

Abstract

Carbapenem-resistant Klebsiella pneumoniae (CRKP) is an emerging nosocomial pathogen. Little is known about its risk factors or mortality. We performed a case-case-control study to assess the risks for CRKP isolation and a retrospective cohort study to assess mortality in three groups of hospitalized adults: (i) patients from whom CRKP was isolated, (ii) patients from whom carbapenem-susceptible Klebsiella spp. (CSKS) were isolated, and (iii) controls from whom no Klebsiella spp. were isolated. After adjustment for length of stay (LOS), the demographics, comorbidities, and exposures of each case group were compared with those of the controls. Significant covariates were incorporated into LOS-adjusted multivariable models. In the mortality study, we evaluated the effect of CRKP on in-hospital death. There were 48 patients with CRKP isolation (21 died [44%]), 56 patients with CSKS isolation (7 died [12.5%]), and 59 controls (1 died [2%]). Independent risk factors for CRKP isolation were poor functional status (odds ratio [OR], 15.4; 95% confidence interval [CI], 4.0 to 58.6; P < 0.001); intensive care unit (ICU) stay (OR, 17.4; 95% CI, 1.5 to 201.9; P = 0.02); and receipt of antibiotics (OR, 4.4; 95% CI, 1.0 to 19.2; P = 0.05), particularly fluoroquinolones (OR, 7.2; 95% CI, 1.1 to 49.4; P = 0.04). CRKP was independently associated with death when patients with CRKP were compared with patients with CSKS (OR, 5.4; 95% CI, 1.7 to 17.1; P = 0.005) and with controls (OR, 6.7; 95% CI, 2.4 to 18.8; P < 0.001). After adjustment for the severity of illness, CRKP isolation remained predictive of death, albeit with a lower OR (for the CRKP group versus the CSKS group, OR, 3.9; 95% CI, 1.1 to 13.6; and P = 0.03; for the CRKP group versus the controls, OR, 5.0; 95% CI, 1.7 to 14.8; and P = 0.004). CRKP affects patients with poor functional status, an ICU stay, and antibiotic exposure and is an independent predictor of death.

摘要

耐碳青霉烯类肺炎克雷伯菌(CRKP)是一种新出现的医院病原体。对其危险因素或死亡率了解甚少。我们进行了一项病例-病例对照研究以评估分离出CRKP的风险,并进行了一项回顾性队列研究以评估三组住院成人的死亡率:(i)分离出CRKP的患者,(ii)分离出对碳青霉烯敏感的克雷伯菌属(CSKS)的患者,以及(iii)未分离出克雷伯菌属的对照。在调整住院时间(LOS)后,将每个病例组的人口统计学、合并症和暴露情况与对照组进行比较。将显著的协变量纳入LOS调整后的多变量模型。在死亡率研究中,我们评估了CRKP对住院死亡的影响。有48例患者分离出CRKP(21例死亡[44%]),56例患者分离出CSKS(7例死亡[12.5%]),59例对照(1例死亡[2%])。分离出CRKP的独立危险因素是功能状态差(比值比[OR],15.4;95%置信区间[CI],4.0至58.6;P<0.001);入住重症监护病房(ICU)(OR,17.4;95%CI,1.5至201.9;P = 0.02);以及接受抗生素治疗(OR,4.4;95%CI,1.0至19.2;P = 0.05),特别是氟喹诺酮类(OR,7.2;95%CI,1.1至49.4;P = 0.04)。当将CRKP患者与CSKS患者进行比较时,CRKP与死亡独立相关(OR,5.4;95%CI,1.7至17.1;P = 0.005),与对照相比也是如此(OR,6.7;95%CI,2.4至18.8;P<0.001)。在调整疾病严重程度后,CRKP分离仍可预测死亡,尽管OR较低(CRKP组与CSKS组相比,OR,3.9;95%CI,1.1至13.6;P = 0.03;CRKP组与对照组相比,OR,5.0;95%CI,1.7至14.8;P = 0.004)。CRKP影响功能状态差、入住ICU和接受抗生素治疗的患者,并且是死亡的独立预测因素。

相似文献

1
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.
Antimicrob Agents Chemother. 2008 Mar;52(3):1028-33. doi: 10.1128/AAC.01020-07. Epub 2007 Dec 17.
2
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
South Med J. 2011 Feb;104(2):106-10. doi: 10.1097/SMJ.0b013e318206063d.
3
Risk Factors for Carbapenem-resistant Infection and Mortality of Infection.
Chin Med J (Engl). 2018 Jan 5;131(1):56-62. doi: 10.4103/0366-6999.221267.
4
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.
J Antimicrob Chemother. 2007 Nov;60(5):1124-30. doi: 10.1093/jac/dkm356. Epub 2007 Sep 20.
5
In-hospital Medical Costs of Infections Caused by Carbapenem-resistant Klebsiella pneumoniae.
Clin Infect Dis. 2018 Nov 13;67(suppl_2):S225-S230. doi: 10.1093/cid/ciy642.
6
Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.
J Hosp Infect. 2013 Apr;83(4):307-13. doi: 10.1016/j.jhin.2012.10.012. Epub 2013 Jan 10.
8
Carbapenem-resistant Klebsiella pneumoniae urinary tract infection following solid organ transplantation.
Antimicrob Agents Chemother. 2015 Jan;59(1):553-7. doi: 10.1128/AAC.04284-14. Epub 2014 Nov 10.
9
Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study.
Colomb Med (Cali). 2014 Jun 30;45(2):54-60. eCollection 2014 Apr-Jun.

引用本文的文献

2
Risk Factors for Non-Carbapenemase-Producing Carbapenem-Resistant Infections: A Retrospective Cohort Study.
Geriatrics (Basel). 2025 May 22;10(3):69. doi: 10.3390/geriatrics10030069.
4
Evaluating the Clinical Benefit of Carbapenem-Resistant Screening in a Tertiary Care Center in Saudi Arabia.
Infect Drug Resist. 2025 May 26;18:2679-2686. doi: 10.2147/IDR.S518397. eCollection 2025.
5
Genomic analysis of carbapenem-resistant blood isolates from nationwide surveillance in South Korea.
Front Microbiol. 2025 May 6;16:1562222. doi: 10.3389/fmicb.2025.1562222. eCollection 2025.
7
Carbapenem-resistant Klebsiella pneumoniae: Risk Factors for Isolation Among Hospitalized Patients.
Brown J Hosp Med. 2022 Dec 16;2(1):57568. doi: 10.56305/001c.57568. eCollection 2023.
10
The Global and Regional Prevalence of Hospital-Acquired Carbapenem-Resistant Infection: A Systematic Review and Meta-analysis.
Open Forum Infect Dis. 2023 Dec 19;11(2):ofad649. doi: 10.1093/ofid/ofad649. eCollection 2024 Feb.

本文引用的文献

1
Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel.
Int J Antimicrob Agents. 2007 Dec;30(6):525-9. doi: 10.1016/j.ijantimicag.2007.07.024. Epub 2007 Oct 10.
2
Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study.
J Antimicrob Chemother. 2007 Nov;60(5):1124-30. doi: 10.1093/jac/dkm356. Epub 2007 Sep 20.
3
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Antimicrob Agents Chemother. 2007 Aug;51(8):3026-9. doi: 10.1128/AAC.00299-07. Epub 2007 Jun 11.
4
Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York.
Clin Infect Dis. 2007 Apr 1;44(7):972-5. doi: 10.1086/512370. Epub 2007 Feb 21.
5
Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing.
Emerg Infect Dis. 2006 Aug;12(8):1209-13. doi: 10.3201/eid1208.060291.
6
7
Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.
Antimicrob Agents Chemother. 2006 Apr;50(4):1257-62. doi: 10.1128/AAC.50.4.1257-1262.2006.
8
Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital.
Clin Infect Dis. 2006 Apr 1;42(7):925-34. doi: 10.1086/500936. Epub 2006 Feb 27.
9
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
Antimicrob Agents Chemother. 2006 Jan;50(1):43-8. doi: 10.1128/AAC.50.1.43-48.2006.
10
Extended-spectrum beta-lactamases: a clinical update.
Clin Microbiol Rev. 2005 Oct;18(4):657-86. doi: 10.1128/CMR.18.4.657-686.2005.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验